Article (Scientific journals)
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Schebb, Nils Helge; Kühn, Hartmut; Kahnt, Astrid S et al.
2022In Frontiers in Pharmacology, 13 (838782), p. 1-22
Peer Reviewed verified by ORBi
 

Files


Full Text
fphar-13-838782.pdf
Publisher postprint (1.32 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
FPR; LC-MS-based lipid mediator analysis; SPM; leukotriene; lipoxin; lipoxygenase; resolution of inflammation; resolvin; Pharmacology (medical); Pharmacology
Abstract :
[en] Formation of specialized pro-resolving lipid mediators (SPMs) such as lipoxins or resolvins usually involves arachidonic acid 5-lipoxygenase (5-LO, ALOX5) and different types of arachidonic acid 12- and 15-lipoxygenating paralogues (15-LO1, ALOX15; 15-LO2, ALOX15B; 12-LO, ALOX12). Typically, SPMs are thought to be formed via consecutive steps of oxidation of polyenoic fatty acids such as arachidonic acid, eicosapentaenoic acid or docosahexaenoic acid. One hallmark of SPM formation is that reported levels of these lipid mediators are much lower than typical pro-inflammatory mediators including the monohydroxylated fatty acid derivatives (e.g., 5-HETE), leukotrienes or certain cyclooxygenase-derived prostaglandins. Thus, reliable detection and quantification of these metabolites is challenging. This paper is aimed at critically evaluating i) the proposed biosynthetic pathways of SPM formation, ii) the current knowledge on SPM receptors and their signaling cascades and iii) the analytical methods used to quantify these pro-resolving mediators in the context of their instability and their low concentrations. Based on current literature it can be concluded that i) there is at most, a low biosynthetic capacity for SPMs in human leukocytes. ii) The identity and the signaling of the proposed G-protein-coupled SPM receptors have not been supported by studies in knock-out mice and remain to be validated. iii) In humans, SPM levels were neither related to dietary supplementation with their ω-3 polyunsaturated fatty acid precursors nor were they formed during the resolution phase of an evoked inflammatory response. iv) The reported low SPM levels cannot be reliably quantified by means of the most commonly reported methodology. Overall, these questions regarding formation, signaling and occurrence of SPMs challenge their role as endogenous mediators of the resolution of inflammation.
Precision for document type :
Review article
Disciplines :
Biochemistry, biophysics & molecular biology
Pharmacy, pharmacology & toxicology
Author, co-author :
Schebb, Nils Helge;  Chair of Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany
Kühn, Hartmut;  Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Kahnt, Astrid S;  Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany
Rund, Katharina M;  Chair of Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany
O'Donnell, Valerie B;  School of Medicine, Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom
Flamand, Nicolas;  Département de Médecine, Faculté de Médecine, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, QC, Canada
Peters-Golden, Marc;  Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States
Jakobsson, Per-Johan;  Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Weylandt, Karsten H;  Division of Medicine, Department of Gastroenterology, Metabolism and Oncology, Ruppin General Hospital, Brandenburg Medical School, Neuruppin, Germany
Rohwer, Nadine;  Division of Medicine, Department of Gastroenterology, Metabolism and Oncology, Ruppin General Hospital, Brandenburg Medical School, Neuruppin, Germany ; Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
Murphy, Robert C;  Department of Pharmacology, University of Colorado-Denver, Aurora, CO, United States
Geisslinger, Gerd;  Institute of Clinical Pharmacology, Pharmazentrum Frankfurt, University Hospital of Goethe-University, Frankfurt, Germany ; Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP and Fraunhofer Cluster of Excellence for Immune Mediated Diseases, CIMD, Frankfurt, Germany
FitzGerald, Garret A;  Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
Hanson, Julien  ;  Université de Liège - ULiège > GIGA > GIGA Molecular Biology of Diseases - Molecular Pharmacology
Dahlgren, Claes;  Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Alnouri, Mohamad Wessam;  Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
Offermanns, Stefan;  Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany ; Center for Molecular Medicine, Goethe University Frankfurt, Frankfurt, Germany
Steinhilber, Dieter;  Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany ; Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP and Fraunhofer Cluster of Excellence for Immune Mediated Diseases, CIMD, Frankfurt, Germany
More authors (8 more) Less
Language :
English
Title :
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Publication date :
02 March 2022
Journal title :
Frontiers in Pharmacology
ISSN :
1663-9812
Publisher :
Frontiers Media SA, Switzerland
Volume :
13
Issue :
838782
Pages :
1-22
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 28 March 2022

Statistics


Number of views
78 (2 by ULiège)
Number of downloads
28 (0 by ULiège)

Scopus citations®
 
66
Scopus citations®
without self-citations
51
OpenCitations
 
18

Bibliography


Similar publications



Contact ORBi